Army Hospital performs India’s first 3D Flex Aqueous Angiography with iStent

Hyderabad: Army Hospital (Research & Referral), Delhi Cantt, successfully performed India’s first 3D Flex Aqueous Angiography with iStent, marking a major milestone in advanced glaucoma treatment.

The Ophthalmology Department carried out the procedure using a new stand-mounted Spectralis imaging system and a state-of-the-art 3D operating microscope. Officials said the achievement placed the Armed Forces Medical Services among global leaders in cutting-edge ophthalmic care.

Doctors explained that glaucoma remains one of the leading causes of irreversible blindness due to its silent progression. However, the introduction of 3D Flex Aqueous Angiography allows real-time visualisation of aqueous outflow pathways. This enables surgeons to plan and execute highly precise, targeted interventions.

The integration of this advanced imaging technique with iStent, a minimally invasive glaucoma surgery, represents a significant shift in treatment strategy. Surgeons can now enhance intraoperative accuracy while improving long-term patient outcomes.

Medical experts said the technology allows better understanding of individual outflow patterns. As a result, it supports personalised surgical decisions and reduces the risk of disease progression.

3D Flex Aqueous Angiography sets new benchmark in glaucoma care

Officials noted that this first-of-its-kind procedure in India established a new benchmark for glaucoma management. It combines minimally invasive surgery with advanced imaging to ensure safer and more effective treatment.

For the Armed Forces community, the development holds strategic importance. It strengthens vision care capabilities while supporting operational readiness through early and effective glaucoma intervention.

Senior specialists said the successful procedure highlighted the Armed Forces Medical Services’ continued focus on innovation and excellence in patient care. They added that the technology could play a key role in shaping the future of glaucoma treatment in India.